OPRX News and Press, OptimizeRx Corporation

2026-02-26 15:41:04 ET According to a recent SEC filing dated February 13, 2026, Whetstone Capital Advisors, LLC reported selling its entire 192,532-share holding in GitLab (NASDAQ:GTLB) . The estimated transaction value, based on the quarter’s average pricing, was approx...

2026-02-21 15:25:30 ET On February 13, 2026, Whetstone Capital Advisors, LLC disclosed in a U.S. Securities and Exchange Commission (SEC) filing that it sold out its entire position in monday.com Ltd. (NASDAQ:MNDY) . According to a filing with the Securities and Exchange Commi...

WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, will hold a conference call on Th...

WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life science companies reach and engage healthcare professionals (HCPs) and patients, today announced at CES 2026 a data...

2025-12-23 10:03:58 ET This article continues my coverage of OptimizeRx ( OPRX ). I last wrote about OPRX back in July 2025 . The company's Q3 2025 earnings results reinforce my long-term bullish thesis for the stock.... Read the full article on Seeking Alpha For fur...

WALTHAM, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced four new partner ag...

2025-12-04 16:38:09 ET More on markets 2026 Prediction: A Tapped-Out Consumer Could Bring The Recession And Market Correction A Weaker Dollar As The Fed Moves Toward Neutral: 3 Calls For FX Feels Normal, But Bounded By Extremes: 3 Calls For Rates Top 5 macro ...

Issued on behalf of Aleen Inc. VANCOUVER – Baystreet.ca News Commentary – Healthcare's artificial intelligence transformation is accelerating at unprecedented speed, with AI spending hitting $1.4 billion this year, nearly tripling 2024's investment as organ...

2025-11-07 05:56:52 ET More on OptimizeRx OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript OptimizeRx: How It Is Changing Pharma Marketing OptimizeRx Non-GAAP EPS of $0.20 beats by $0.15, revenue of $26.1M beats by $2.41M OptimizeRx Q3 2025 Earn...

2025-11-07 05:56:09 ET OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST... Read the full article on Seeking Alpha For further details see: OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript